Because PDE5 inhibitors seem to increase BTB permeability to high molecular weight drugs, they might enhance brain tumor accumulation and thus, therapeutic efficacy of other classes of drugs including emerging nanomedicines [42]. Here, PDE5A is linked to brain neoplasm.